Anemia Severity Associated with Increased Healthcare Utilization and Costs in Inflammatory Bowel Disease

Background Anemia is a common systemic complication of inflammatory bowel disease (IBD) and is associated with worse disease outcomes, quality of life, and higher healthcare costs. Aims The purpose of this study was to determine how anemia severity impacts healthcare resource utilization and if trea...

Full description

Saved in:
Bibliographic Details
Published in:Digestive diseases and sciences 2021-08, Vol.66 (8), p.2555-2563
Main Authors: Blaney, Hanna, Vu, Peter, Mathew, Antony, Snelling, Robin, England, Julie, Duong, Camille, Hammonds, Kendall, Johnson, Christopher
Format: Article
Language:English
Subjects:
Analysis
Anemia
Biochemistry
Gastroenterology
Gastrointestinal diseases
Health services utilization
Hepatology
Inflammatory bowel disease
Medical care
Medical care, Cost of
Medicine
Medicine & Public Health
Oncology
Original Article
Transplant Surgery
Utilization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Anemia is a common systemic complication of inflammatory bowel disease (IBD) and is associated with worse disease outcomes, quality of life, and higher healthcare costs. Aims The purpose of this study was to determine how anemia severity impacts healthcare resource utilization and if treatment of anemia was associated with reduced utilization and costs. Methods Retrospective chart review of adult patients managed by gastroenterology between 2014 and 2018 at a tertiary referral center. Results The records of 1763 patients with IBD were included in the analysis, with 966 (55%) patients with CD, 799 (44%) with UC, and 18 (1%) with unspecified IBD. Of these patients, 951 (54%) had anemia. Patients with anemia had significantly more hospitalizations, increased length of stays, more ER, GI, and PCP visits, as well as higher costs when compared to patients with IBD without anemia. Patients with more severe anemia had more healthcare utilization and incurred even higher total costs. Treatment with IV or oral iron did not lower overall utilization or costs, when compared to patients with anemia who did not receive treatment ( p 
ISSN:0163-2116
1573-2568
DOI:10.1007/s10620-020-06590-y